Fortrea (FTRE) PT Lowered to $12 at Barclays
Tweet
Share
E-mailGet Alerts FTRE Hot Sheet
Price: $18.13 -0.06%
Rating Summary:
5 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Rating Summary:
5 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Join SI Premium – FREE
Barclays analyst Luke Sergott lowered the price target on Fortrea (NASDAQ: FTRE) to $12.00 (from $15.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- HCA Healthcare Inc (HCA) PT Lowered to $425 at JPMorgan
- Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
